-transparent.png){kind=logo}
Binding of [3H]thyrotropin-releasing hormone (TRH) to its receptors in the rat limbic forebrain was partially displaced by 5-hydroxytryptamine (5-HT, ligand for 5-HT1 receptors) and (+)-lysergic acid diethylamide ((+)-LSD, ligand for 5-HT1 and 5-HT2 receptors) at nanomolar concentrations. Spiperone (ligand for 5-HT2 receptors) displaced [3H]TRH in a dose-dependent manner at micromolar concentrations. These results suggest that some TRH receptors are related to 5-HT1 receptors, probably adjoining them on the membrane. This type of TRH receptor is shown to be among the high-affinity receptors which we reported previously. The significance of the receptor-coexistence is such that TRH facilitates serotonergic transmission by increasing the density of 5-HT1 receptors. This finding seems to support a pharmacological observation of other investigators that TRH potentiates 5-HT-induced hyperactivity in mice, probably by affecting postsynaptic 5-HT receptors.
S Teshima, and
K Funatsu, and
H Satoh, and
K Inanaga
January 1992,
Methods in enzymology,
S Teshima, and
K Funatsu, and
H Satoh, and
K Inanaga
November 1979,
Molecular pharmacology,
S Teshima, and
K Funatsu, and
H Satoh, and
K Inanaga
January 1978,
Molecular pharmacology,
S Teshima, and
K Funatsu, and
H Satoh, and
K Inanaga
July 1953,
The Journal of physiology,
S Teshima, and
K Funatsu, and
H Satoh, and
K Inanaga
January 1984,
European journal of pharmacology,
S Teshima, and
K Funatsu, and
H Satoh, and
K Inanaga
January 1981,
Journal de physiologie,
S Teshima, and
K Funatsu, and
H Satoh, and
K Inanaga
August 2001,
Psychoneuroendocrinology,
S Teshima, and
K Funatsu, and
H Satoh, and
K Inanaga
February 1988,
Experientia,
S Teshima, and
K Funatsu, and
H Satoh, and
K Inanaga
October 1987,
Regulatory peptides,
S Teshima, and
K Funatsu, and
H Satoh, and
K Inanaga
March 1968,
Life sciences,
